“…They have demonstrated efficacy in attenuating ARS, with antimicrobials such as tetracyclines ( Kim et al, 2009 ; Epperly et al, 2010 ) and fluoroquinolones ( Kim et al, 2009 ) showing promise as radiation mitigators. Antibiotics such as minocycline are also in clinical trials as neuroprotective treatments for patients undergoing metastatic brain tumor radiotherapy ( Afshari et al, 2020 ). Further, NASA has investigated use of minocycline as a prophylactic MCM due to its antibiotic, anti-apoptotic, anti-inflammatory, and immunomodulatory properties ( Mehrotra et al, 2013 ; Zhang et al, 2014 ).…”